Kite Pharma

Updated: August 05, 2025
Arie Belldegrun, founder
Arie Belldegrun, founder
Country: USA | Funding: $335.4M (+)

Website: https://www.kitepharma.com/

Kite Pharma is a development-stage biotechnology company designing and developing immune-based therapies to treat cancer indications. Acquired by Gilead Sciences




Competitors